Inflammation: therapeutic targets for diabetic neuropathy (Q38132718)

29 August 2017

Inflammation: therapeutic targets for diabetic neuropathy (English)

1 reference

29 August 2017

0 references

Jiyin Zhou

1

1 reference

PubMed ID

23990376

29 August 2017

Shiwen Zhou

series ordinal

2

1 reference

29 August 2017

30 August 2013

1 reference

29 August 2017

Molecular Neurobiology

1 reference

29 August 2017

49

1 reference

29 August 2017

1

1 reference

29 August 2017

536-546

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-013-8537-0

29 August 2017

0 references

cites work

Diabetic neuropathy: mechanisms to management

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, peripheral diabetic polyneuropathy, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Diabetic neuropathy: cellular mechanisms as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

21 January 2018

Iatrogenic neuropathies

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Therapy of chemotherapy-induced peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Suprascapular neuropathy: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Angiogenesis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Transient expression of hypoxia-inducible factor-1 alpha and target genes in peripheral nerves from diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Hypoxia-induced apoptosis of dorsal root ganglion neurons is associated with DNA damage recognition and cell cycle disruption in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

TNF-alpha expression in painful and nonpainful neuropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Inactivation of TNF-α ameliorates diabetic neuropathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

TNF-alpha and neuropathic pain--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Plasma adiponectin, IL-6, hsCRP, and TNF-α levels in subject with diabetic foot and their correlation with clinical variables in a North Indian tertiary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

C-reactive protein as an outcome predictor for percutaneous transluminal angioplasty in diabetic patients with peripheral arterial disease and infected foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Role of angiotensin II in the brain inflammatory events during experimental diabetes in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Targeting of myelin protein zero in a spontaneous autoimmune polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Inflammatory cytokine and chemokine expression is differentially modulated acutely in the dorsal root ganglion in response to different nerve root compressions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Possible contribution of adipocytokines on diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Type 2 diabetes as an inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

New perspectives on the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Sciatic nerve of diabetic rat treated with epoetin delta: effects on C-fibers and blood vessels including pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

COMP-angiopoietin-1 recovers molecular biomarkers of neuropathy and improves vascularisation in sciatic nerve of ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: anti-inflammatory and antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Metanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Factors That Impact Symptomatic Diabetic Peripheral Neuropathy in Placebo-Administered Patients From Two 1-Year Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Beneficial Effects of PKF275-055, a Novel, Selective, Orally Bioavailable, Long-Acting Dipeptidyl Peptidase IV Inhibitor in Streptozotocin-Induced Diabetic Peripheral Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8537-0

Study of the role of interleukin-6 and highly sensitive C-reactive protein in diabetic nephropathy in type 1 diabetic patients.

21 January 2018

1 reference

12 December 2020

The impact of reversal of hypoxia by revascularization on the peripheral nerve function of diabetic patients

1 reference

12 December 2020

Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus

1 reference

12 December 2020

Electrophysiological changes, plasma vascular endothelial growth factor, fatty acid synthase, and adhesion molecules in diabetic neuropathy

1 reference

12 December 2020

The effects of hyperglycaemic hypoxia on rectification in rat dorsal root axons

1 reference

12 December 2020

Effects of hypoxia and severity of diabetes on Na,K-ATPase activity and arachidonoyl-containing glycerophospholipid molecular species in nerve from streptozotocin diabetic rats

1 reference

12 December 2020

Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM

1 reference

12 December 2020

Association of tumor necrosis factor alpha, interferon gamma and interleukin 10 gene polymorphisms with peripheral neuropathy in South Indian patients with type 2 diabetes

1 reference

12 December 2020

IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group

1 reference

12 December 2020

Effects of interleukin-6 treatment on neurovascular function, nerve perfusion and vascular endothelium in diabetic rats

1 reference

12 December 2020

Impact of cytokines on the pathomechanism of diabetic and alcoholic neuropathies

1 reference

12 December 2020

The last defence? Surgical aspects of gouty arthritis of hand and wrist

1 reference

12 December 2020

The potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy

1 reference

12 December 2020

Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy

1 reference

12 December 2020

Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms

1 reference

12 December 2020

JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence

1 reference

12 December 2020

A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis

1 reference

12 December 2020

Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades

1 reference

12 December 2020

[Serum levels of pro-inflammatory cytokines in diabetic patients with peripheral neuropathic pain and the correlation among them]

1 reference

12 December 2020

The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model

1 reference

12 December 2020

Suprascapular neuropathy

1 reference

12 December 2020

Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain

1 reference

12 December 2020

Spinal astrocytic activation contributes to mechanical allodynia in a mouse model of type 2 diabetes

1 reference

12 December 2020

Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus

1 reference

12 December 2020

The relationship between leptin and the insulin resistance syndrome is disturbed in type 2 diabetic subjects with parasympathetic neuropathy

1 reference

12 December 2020

RETRACTED: Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1016/J.CYTO.2018.03.015

Identifiers

DOI

10.1007/S12035-013-8537-0

1 reference

PubMed ID

23990376

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

23990376